Kirkland & Ellis LLP

M&A: Large Deals ($1bn+); Shareholder Activism

Graham Robinson is an M&A partner in the Boston office of Kirkland & Ellis LLP. Graham’s practice focuses on transactions involving the acquisitions of public companies, specifically within the biopharmaceutical industry. He is ranked first by deal value and number of deals among U.S. attorneys for public biotechnology M&A transactions since January 2016, according to Deal Point Data. Graham also has extensive experience within the shareholder activism space. He has helped companies prepare for and respond to unsolicited acquisition proposals, as well as dealing with activist investors. He provides counsel to boards of directors and special committees on corporate governance matters and internal investigations.

Former partner,  Skadden, Arps, Slate, Meagher & Flom LLP

Overseer, Boston Symphony Orchestra

Former Member of the Board of Fellows, Harvard Medical School

Former Member of the Board of Directors, Massachusetts Chapter of the March of Dimes

Harvard Law School, J.D., 1999

University of Pennsylvania, B.A., 1996